S&P 500   3,002.33 (+0.54%)
DOW   26,791.38 (+0.08%)
QQQ   193.03 (+0.70%)
AAPL   240.25 (+1.62%)
MSFT   137.67 (+0.19%)
AMZN   1,778.61 (+1.20%)
CGC   20.12 (-0.45%)
NVDA   195.46 (+2.61%)
MU   44.91 (+3.31%)
BABA   171.98 (+1.68%)
TSLA   255.12 (-0.71%)
AMD   32.04 (+3.46%)
T   38.37 (-0.26%)
F   9.11 (-1.94%)
ACB   3.62 (-1.63%)
NFLX   276.03 (+0.27%)
BAC   31.10 (+2.44%)
DIS   130.83 (-0.05%)
S&P 500   3,002.33 (+0.54%)
DOW   26,791.38 (+0.08%)
QQQ   193.03 (+0.70%)
AAPL   240.25 (+1.62%)
MSFT   137.67 (+0.19%)
AMZN   1,778.61 (+1.20%)
CGC   20.12 (-0.45%)
NVDA   195.46 (+2.61%)
MU   44.91 (+3.31%)
BABA   171.98 (+1.68%)
TSLA   255.12 (-0.71%)
AMD   32.04 (+3.46%)
T   38.37 (-0.26%)
F   9.11 (-1.94%)
ACB   3.62 (-1.63%)
NFLX   276.03 (+0.27%)
BAC   31.10 (+2.44%)
DIS   130.83 (-0.05%)
Log in

Polynovo Stock Price, News & Analysis (ASX:PNV)

A$2.44
+0.04 (+1.67 %)
(As of 10/21/2019 11:49 AM ET)
Today's Range
A$2.30
Now: A$2.44
A$2.47
50-Day Range
A$1.49
MA: A$2.14
A$2.58
52-Week Range
A$0.51
Now: A$2.44
A$2.66
Volume2.66 million shs
Average VolumeN/A
Market Capitalization$1.61 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Polynovo Limited, a medical device company, designs, develops, and manufactures dermal regeneration solutions in Australia. The company focuses on the development and commercialization of medical devices using its NovoSorb technology in the treatment of burns, surgical wounds, and negative pressure wound therapy. It offers BTM (biodegradable temporising matrix), a wound dressing intended for treatment of full-thickness wounds and burns. In addition, Polynovo Limited licensed its NovoSorb to Smith & Nephew for orthopaedic applications. The company was formerly known as Calzada Limited and changed its name to Polynovo Limited in November 2014. Polynovo Limited is based in Port Melbourne, Australia.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 3 8681 4050

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$14.04 million
Cash FlowA$0.02 per share
Book ValueA$0.04 per share

Profitability

Miscellaneous

Employees41
Market Cap$1.61 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive PNV News and Ratings via Email

Sign-up to receive the latest news and ratings for PNV and its competitors with MarketBeat's FREE daily newsletter.


Polynovo (ASX:PNV) Frequently Asked Questions

What is Polynovo's stock symbol?

Polynovo trades on the ASX under the ticker symbol "PNV."

Has Polynovo been receiving favorable news coverage?

Media stories about PNV stock have trended somewhat positive this week, according to InfoTrie Sentiment. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Polynovo earned a news impact score of 0.8 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Polynovo.

Who are some of Polynovo's key competitors?

What other stocks do shareholders of Polynovo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Polynovo investors own include IMMUTEP LTD/S (IMMP), Rural Funds Group (RFF), Vanguard FTSE Pacific ETF (VPL), Align Technology (ALGN) and Acasti Pharma (ACST).

Who are Polynovo's key executives?

Polynovo's management team includes the folowing people:
  • Mr. Paul Brennan, Chief Exec. Officer
  • Mr. Greg Lewis M.A.I.C.D., M.B.A., Chief Operating Officer
  • Mr. Jan-Marcel Gielen, CFO & Company Sec.
  • Dr. Tim Moore, Principal Scientist
  • Mr. David Smith, Manufacturing Mang.

What is Polynovo's stock price today?

One share of PNV stock can currently be purchased for approximately A$2.44.

How big of a company is Polynovo?

Polynovo has a market capitalization of $1.61 billion and generates $14.04 million in revenue each year. Polynovo employs 41 workers across the globe.View Additional Information About Polynovo.

What is Polynovo's official website?

The official website for Polynovo is http://www.polynovo.com.au/.

How can I contact Polynovo?

The company can be reached via phone at 61 3 8681 4050.


MarketBeat Community Rating for Polynovo (ASX PNV)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  15 (Vote Outperform)
Underperform Votes:  14 (Vote Underperform)
Total Votes:  29
MarketBeat's community ratings are surveys of what our community members think about Polynovo and other stocks. Vote "Outperform" if you believe PNV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PNV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Featured Article: Market Perform

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel